LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

37.64 0.43

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

37.5

Max

38.02

Pagrindiniai rodikliai
By Trading Economics
Pajamos	11M 51M
Pardavimai	39M 239M
P/E Sektoriaus vid.	12.278 76.798
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	21.242
Darbuotojai	268
EBITDA	14M 73M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+21.66% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	554M 2.2B
Ankstesnė atidarymo kaina	37.21
Ankstesnė uždarymo kaina	37.64

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-19 17:29; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

2025-12-19 16:47; UTC

Pagrindinės rinkos jėgos

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

2025-12-19 16:10; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

2025-12-20 19:00; UTC

Uždarbis

Consumer Confidence, Economic Activity Data, and a Short Trading Week for Christmas -- Barrons.com

2025-12-19 22:33; UTC

Uždarbis

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

2025-12-19 22:19; UTC

Uždarbis

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

2025-12-19 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025-12-19 21:44; UTC

Uždarbis

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

2025-12-19 21:38; UTC

Uždarbis

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

2025-12-19 21:00; UTC

Rinkos pokalbiai

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

2025-12-19 20:23; UTC

Rinkos pokalbiai

Oil Futures End Down Week on Up Note -- Market Talk

2025-12-19 20:14; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

2025-12-19 18:38; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

2025-12-19 18:00; UTC

Rinkos pokalbiai

Uždarbis

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

2025-12-19 17:41; UTC

Uždarbis

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

2025-12-19 17:24; UTC

Rinkos pokalbiai

Uždarbis

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

2025-12-19 17:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-19 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-12-19 16:29; UTC

Uždarbis

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

2025-12-19 16:20; UTC

Įsigijimai, susijungimai, perėmimai

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

2025-12-19 16:19; UTC

Įsigijimai, susijungimai, perėmimai

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

2025-12-19 16:18; UTC

Įsigijimai, susijungimai, perėmimai

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

2025-12-19 16:16; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-19 16:16; UTC

Rinkos pokalbiai

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

2025-12-19 16:05; UTC

Įsigijimai, susijungimai, perėmimai

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025-12-19 16:04; UTC

Įsigijimai, susijungimai, perėmimai

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025-12-19 15:37; UTC

Rinkos pokalbiai

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

2025-12-19 15:21; UTC

Rinkos pokalbiai

West-Coast Liquor Store Strike Weighed on Canada Retail Data -- Market Talk

2025-12-19 15:09; UTC

Rinkos pokalbiai

Gold Flat But Set for Weekly Gains -- Market Talk

2025-12-19 15:09; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

21.66% į viršų

12 mėnesių prognozė

Vidutinis 46 USD 21.66%

Aukščiausias 62 USD

Žemiausias 32 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

10 ratings

Pirkti

Laikyti

Parduoti

Remiantis 10 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.